Advertisement
Advertisement
U.S. markets close in 2 hours 54 minutes
Advertisement
Advertisement
Advertisement
Advertisement

vTv Therapeutics Inc. (VTVT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3450+0.0550 (+4.26%)
As of 01:02PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.2900
Open1.2900
Bid1.3300 x 1300
Ask1.3500 x 1100
Day's Range1.2900 - 1.4000
52 Week Range0.3820 - 2.1700
Volume283,795
Avg. Volume958,364
Market Cap104.008M
Beta (5Y Monthly)-1.37
PE Ratio (TTM)N/A
EPS (TTM)-0.2490
Earnings DateAug 15, 2022 - Aug 22, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VTVT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • vTv Therapeutics Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
Advertisement
Advertisement